Clinical and Experimental Nephrology · Nov 14, 2026
Associations of dietary magnesium intake with glomerular and tubular injury markers in type 2 diabetes: The Fukuoka Diabetes Registry
By Ohmura I, Ohkuma T, Iwase M et al.
Background Higher dietary magnesium intake has been associated with reduced risk of cardiovascular disease and its risk factors. However, its association with CKD remains unclear. This study examined this association using glomerular and tubular injury markers. Methods A total of 4,923 participants with type 2 diabetes were classified into quintiles of dietary magnesium intake. CKD was defined as decreased estimated glomerular filtration rate (eGFRcr <60 mL/min/1.73 m²) and/or albuminuria (urinary albumin-to-creatinine ratio [UACR] ≥ 30 mg/g). Odds ratios (ORs) for CKD were calculated using logistic regression. Associations of dietary magnesium intake with eGFRcr, UACR, neutrophil gelatinase-associated lipocalin (NGAL), liver-type fatty acid-binding protein (L-FABP), and kidney injury molecule-1 (KIM-1) were evaluated using linear regression. Results Higher dietary magnesium intake was associated with lower prevalence of CKD. Compared with the lowest quintile, the multivariable-adjusted ORs (95% confidence intervals) for CKD across increasing quintiles were 0.84 (0.68–1.04), 0.73 (0.57–0.93), 0.58 (0.44–0.76), and 0.50 (0.35–0.71) (P for trend < 0.001). Similar inverse associations were observed for decreased eGFRcr and albuminuria analyzed separately. Higher magnesium intake was also associated with lower urinary NGAL and L-FABP. Conclusions These findings suggest a potential role of dietary magnesium intake in preserving glomerular and tubular kidney health.
doi.org/10.1007/s10157-026-02979-7PubMed 43033316Populations